In Conversation

“ I want Wacker Biotech to be recognised for its scientific expertise, speed, collaboration, and flexibility ”

“ 70 percent of healthcare decisions are influenced by diagnostic results, yet we spend just 2.5 percent of our healthcare budget on them ”

“ Despite all the changes, the US remains the premier market for our investment and where much of our future success will depend ”

“ I emphasise cross-pollination between our Korean and US teams: drawing on the best practices from both sides ”

“ Even though the austerity law has had an unpleasant impact on everyone in the system, it had to be done ”

“ Ultimately, healthcare is always about people, not numbers in a spreadsheet ”

“ Legend is looking at all ways to bring CAR-T to more patients, including allogeneic, autologous, and in vivo approaches ”

“ Our next phase of evolution is moving from pure-play generics to something more complex across branded products, biosimilars, and NCEs ”

“ Our mission has remained constant: to develop and provide cancer patients with precise treatment and early detection, and to improve patient outcomes ”

“ Taiwan's investment culture remains heavily oriented toward semiconductors and electronics, and  few investors are yet convinced to commit capital to biotech ”

“ Our DNA, the fundamentals, and the strategy have served us well for the past 35 years and will continue to guide us ”